Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
07 2020
Historique:
received: 27 09 2019
revised: 01 04 2020
accepted: 03 04 2020
pubmed: 12 4 2020
medline: 21 10 2020
entrez: 12 4 2020
Statut: ppublish

Résumé

Observational studies point to an inverse correlation between low-density lipoprotein (LDL) cholesterol levels and risk of intracerebral hemorrhage (ICH), but it remains unclear whether this association is causal. We tested the hypothesis that genetically elevated LDL is associated with reduced risk of ICH. We constructed one polygenic risk score (PRS) per lipid trait (total cholesterol, LDL, high-density lipoprotein [HDL], and triglycerides) using independent genomewide significant single nucleotide polymorphisms (SNPs) for each trait. We used data from 316,428 individuals enrolled in the UK Biobank to estimate the effect of each PRS on its corresponding trait, and data from 1,286 ICH cases and 1,261 matched controls to estimate the effect of each PRS on ICH risk. We used these estimates to conduct Mendelian Randomization (MR) analyses. We identified 410, 339, 393, and 317 lipid-related SNPs for total cholesterol, LDL, HDL, and triglycerides, respectively. All four PRSs were strongly associated with their corresponding trait (all p < 1.00 × 10 Genetically elevated LDL levels were associated with lower risk of ICH, providing support for a potential causal role of LDL cholesterol in ICH. ANN NEUROL 2020 ANN NEUROL 2020;88:56-66.

Identifiants

pubmed: 32277781
doi: 10.1002/ana.25740
pmc: PMC7523882
mid: NIHMS1608154
doi:

Substances chimiques

Cholesterol, HDL 0
Cholesterol, LDL 0
Triglycerides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-66

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS086873
Pays : United States
Organisme : Wellcome Trust
ID : 212946/Z/18/Z
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : K76 AG059992
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021342
Pays : United States
Organisme : Medical Research Council
ID : MC_U137686851
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_13049
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS036695
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_14135
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : K07 AG043587
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12026/2
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS103924
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS069763
Pays : United States
Organisme : NINDS NIH HHS
ID : R03 NS112859
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00017/1
Pays : United Kingdom

Informations de copyright

© 2020 American Neurological Association.

Références

Annu Rev Pharmacol Toxicol. 2005;45:89-118
pubmed: 15822172
Nature. 2010 Oct 28;467(7319):1061-73
pubmed: 20981092
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Stroke. 2012 Aug;43(8):2149-56
pubmed: 22588266
Am J Hum Genet. 2014 Apr 3;94(4):511-21
pubmed: 24656865
Mult Scler Relat Disord. 2018 Aug;24:72-78
pubmed: 29960142
Genome Med. 2017 Nov 13;9(1):96
pubmed: 29132412
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Nature. 2018 Oct;562(7726):194-195
pubmed: 30305754
Stroke. 2009 Mar;40(3 Suppl):S64-6
pubmed: 19150865
Nat Genet. 2018 Nov;50(11):1514-1523
pubmed: 30275531
Nucleic Acids Res. 2014 Jan;42(Database issue):D975-9
pubmed: 24297256
Stroke. 2002 May;33(5):1190-5
pubmed: 11988589
Neurology. 2008 Jun 10;70(24 Pt 2):2364-70
pubmed: 18077795
J Korean Med Sci. 2011 May;26(5):631-6
pubmed: 21532853
Nat Med. 2019 Apr;25(4):569-574
pubmed: 30858617
Blood Vessels. 1978;15(1-3):148-56
pubmed: 630129
Neurology. 2012 Dec 4;79(23):2275-82
pubmed: 23175721
Int J Methods Psychiatr Res. 2018 Jun;27(2):e1608
pubmed: 29484742
Nat Genet. 2013 Nov;45(11):1274-1283
pubmed: 24097068
Clin Chem. 2009 Mar;55(3):407-19
pubmed: 19168552
Nat Genet. 2018 Mar;50(3):401-413
pubmed: 29507422
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Stroke. 2017 Dec;48(12):3420-3424
pubmed: 29114093
Curr Epidemiol Rep. 2015;2(3):180-190
pubmed: 26269782
Neurology. 2007 Mar 6;68(10):737-42
pubmed: 17182976
Stroke. 2013 Feb;44(2):321-6
pubmed: 23321443
Ann Hum Genet. 2011 May;75(3):418-27
pubmed: 21281271
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
Stroke. 2011 Sep;42(9):2447-52
pubmed: 21799167
Ann Neurol. 2010 Dec;68(6):934-43
pubmed: 21061402
Acta Neurol Scand. 2016 Jul;134(1):22-8
pubmed: 26647879
J Stroke. 2017 Jan;19(1):3-10
pubmed: 28178408
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Ann Neurol. 2016 Nov;80(5):730-740
pubmed: 27717122
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
J Lipids. 2015;2015:971453
pubmed: 25949827

Auteurs

Guido J Falcone (GJ)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Elayna Kirsch (E)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Julian N Acosta (JN)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Rommell B Noche (RB)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Audrey Leasure (A)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Sandro Marini (S)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.

Jaeyoon Chung (J)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.

Magdy Selim (M)

Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.

James F Meschia (JF)

Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

Devin L Brown (DL)

Stroke Program, Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA.

Bradford B Worrall (BB)

Department of Neurology and Public Health Sciences, University of Virginia Health System, Charlottesville, VA, USA.

David L Tirschwell (DL)

Stroke Center, Harborview Medical Center, University of Washington, Seattle, WA, USA.

Jeremiasz M Jagiella (JM)

Department of Neurology, Jagiellonian University Medical College, Kraków, Poland.

Helena Schmidt (H)

Institute of Molecular Biology and Medical Biochemistry, Medical University Graz, Graz, Austria.

Jordi Jimenez-Conde (J)

Neurovascular Research Unit, Department of Neurology, Institut Municipal d'Investigacio' Medica-Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain.
Program in Inflammation and Cardiovascular Disorders, Institut Municipal d'Investigacio' Medica-Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain.

Israel Fernandez-Cadenas (I)

Neurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Arne Lindgren (A)

Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
Department of Neurology, Skåne University Hospital, Lund, Sweden.

Agnieszka Slowik (A)

Department of Neurology, Jagiellonian University Medical College, Kraków, Poland.

Dipender Gill (D)

Department of Epidemiology and Biostatistics and Department of Stroke Medicine, Imperial College London, London, UK.

Michael Holmes (M)

Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.

Chia-Ling Phuah (CL)

Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.

Nils H Petersen (NH)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Charles N Matouk Md (CN)

Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.

Murat Gunel (M)

Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.

Lauren Sansing (L)

Division of Vascular Neurology and Stroke, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Derrick Bennett (D)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.

Zhengming Chen (Z)

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.

Luan L Sun (LL)

Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Robert Clarke (R)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Robin G Walters (RG)

Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.

Thomas M Gill (TM)

Department of Internal Medicine, Geriatric Medicine, Yale School of Medicine, New Haven, CT, USA.

Alessandro Biffi (A)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
Division of Behavioral Neurology, Department of Neurology, MGH, Boston, MA, USA.
Division of Psychiatry, Department of Psychiatry, MGH, Boston, MA, USA.

Sekar Kathiresan (S)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
Cardiovascular Disease Prevention Center, MGH, Boston, MA, USA.

Carl D Langefeld (CD)

Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Daniel Woo (D)

Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Jonathan Rosand (J)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
Department of Neurology, MGH, Boston, MA, USA.
Henry and Allison McCance Center for Brain Health, MGH, Boston, MA, USA.

Kevin N Sheth (KN)

Division of Neurocritical Care & Emergency Neurology, Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

Christopher D Anderson (CD)

Center for Genomic Medicine, Massachusetts General Hospital (MGH), Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
Department of Neurology, MGH, Boston, MA, USA.
Henry and Allison McCance Center for Brain Health, MGH, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH